Results 251 to 260 of about 295,251 (340)

Thyroid Dysfunction in Patients With End-Stage Renal Disease: A Single-Centered Experience From Pakistan. [PDF]

Cureus
German S, Bhatti S, Waqar T, Lashari S, Mehmood M, Rizwan A, Ali H, Taha Yaseen R.   +7 more
europepmc   +1 more source

African-Americans with type I insulin-dependent diabetes mellitus and end-stage renal disease: Results after simultaneous pancreas-kidney transplantation

, 1997
George W. Burke, Gaetano Ciancio, J. Colona, David Roth, J. Miller   +4 more
openalex   +1 more source

Outcome of Patients With Lupus Nephritis Treated With an Anti‐CD40 Monoclonal Antibody According to Kidney Biopsy Features

Arthritis &Rheumatology, EarlyView.
Objective A phase 2 trial tested different doses of the anti‐CD40 monoclonal antibody BI 655064 as an add‐on therapy to the standard of care in patients with class III or IV lupus nephritis (LN) with active disease. A post hoc analysis showed a potential benefit of the higher tested doses (180 and 240 mg) versus a low dose (120 mg) or placebo.
Martina Uzzo, Helmut Schumacher, Juergen Steffgen, Simone Deutschel, David Jayne, Ingeborg Bajema   +5 more
wiley   +1 more source

Abdominal subcutaneous fat area can predict 2-year survival in patients with end-stage renal disease initiating hemodialysis. [PDF]

PLoS One
Choi W, Park H, Park H, Chang YK, Choi DE.   +4 more
europepmc   +1 more source

Drug-related low responsiveness to recombinant human erythropoietin therapy in three patients with end-stage renal disease

, 1997
Yuji Ikeda, Takanobu Sakemi, Yoko Ohtsuka, Morimasa Kuwahara, Noritomo Fujisaki   +4 more
openalex   +1 more source

Absence of Functional Autoantibodies Targeting Angiotensin II Receptor Type 1 and Endothelin‐1 Type A Receptor in Circulation and Purified IgG From Patients With Systemic Sclerosis

Arthritis &Rheumatology, EarlyView.
Objective Systemic sclerosis (SSc) is a rare but severe autoimmune disease characterized by immune dysregulation, fibrosis, and vasculopathy. Although previous studies have highlighted the presence of functional autoantibodies targeting the angiotensin II receptor type 1 (AT1) and endothelin‐1 type A receptor (ETAR), leading to autoantibody‐mediated ...
Wieke M. van Oostveen, Eva M. Hoekstra, E. W. Nivine Levarht, Ilana B. Kotliar, Thomas P. Sakmar, René E. M. Toes, Jeska K. de Vries‐Bouwstra, Laura H. Heitman, Cynthia M. Fehres   +8 more
wiley   +1 more source

GIR6 Predictors of Diagnostic-Related Group Day Outliers in the Medicare End-Stage Renal Disease Population

, 1998
Isabel Vilas-Boas
openalex   +1 more source

Long‐Term Safety and Efficacy of Mepolizumab in Eosinophilic Granulomatosis With Polyangiitis

Arthritis &Rheumatology, EarlyView.
Objective Eosinophilic granulomatosis with polyangiitis (EGPA) is a rare, relapsing, inflammatory disease. Management of EGPA predominantly relies on oral corticosteroids (OCS), which are associated with many adverse effects. The phase 3 MIRRA trial demonstrated efficacy and safety of mepolizumab, anti‐interleukin‐5 biologic, for EGPA.
Michael E. Wechsler, Jared Silver, Gerhard Wolff, Robert G. Price, Rejina Verghis, Peter F. Weller, Peter A. Merkel, Paneez Khoury, on behalf of the EGPA Mepolizumab Open‐Label Extension study group, Arnaud Bourdin, Pascal Chanez, Anoop Chauhan, Vincent Cottin, Gerald Gleich, Berhnard Hellmich, Tomonori Ishii, David Jayne, Jean‐Emmanuel Kahn, Peter Kern, Nader Khalidi, Ina Koetter, Carol Langford, Amy Markezich, Paul Monach, Shamsa Naveed, Peter Oelzner, Kenneth Pinna, Xavier Puechal, Emory H. Robinette, Florence Roufosse, Reinhard Voll, Andrew Schafer, Kaharu Sumino, Masami Taniguchi, Phillip Lieberman   +34 more
wiley   +1 more source

Fatal adenovirus meningoencephalitis in end stage renal disease patient

International Journal of Infectious Diseases, 2020
X.K. Cheong, C.L. Lau, L.S. Loong, M.K. Yin, F.W. Tajuruddin, P. Periyasamy, N. Kori   +6 more
doaj  

Brain surface area and function alterations are correlated with cognition in patients with end-stage renal disease. [PDF]

Quant Imaging Med Surg
Wang C, Song L, Liu X, Yang W, Li M, Xu B, Yang Z, Liu W, Wang ZC, Wang H.   +9 more
europepmc   +1 more source